Literature DB >> 26537262

POSITION OF THE SBCBM - NOMENCLATURE AND DEFINITION OF OUTCOMES OF BARIATRIC AND METABOLIC SURGERY.

Luis V Berti1, Josemberg Campos1, Almino Ramos1, Marçal Rossi1, Thomas Szego1, Ricardo Cohen1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26537262      PMCID: PMC4795295          DOI: 10.1590/S0102-6720201500S100002

Source DB:  PubMed          Journal:  Arq Bras Cir Dig        ISSN: 0102-6720


× No keyword cloud information.
Obesity was initially regarded as a psychosocial disorder, but, after years of study, has come to be understood as a chronic disease for which there is no cure, like hypertension and diabetes6 , 7. Surgical intervention is safe and effective in the long term and aims to control the disease and its comorbidities. Even so, it is hoped that the proportion of patients who experience long-term recidivism can be reduced1 , 3. In the past 20 years, surgical treatment of obesity has evolved significantly and is regarded as more than an isolated modification of the digestive tract. This operation, in combination with changes in lifestyle, is fundamental for controlling the disease in the long and medium term. These changes can be achieved with appropriate guidance and follow-up from a multi-professional team5. Comorbidities, such as diabetes, arterial hypertension, sleep apnea and others, reduce quality of life and increase mortality. Weight loss and control of these disease save lives and bring down the cost to the healthcare system2, 4 , 8. There is no consensus in the literature as to the definition of successful bariatric and metabolic surgery. The same outcome can be considered favorable by one author and unfavorable by another. There is also no unanimity as which treatment option is most appropriate for turning round a failed bariatric surgery. With a view to drawing up norms as to what constitutes successful bariatric surgery, the Brazilian Society of Bariatric and Metabolic Surgery-SBCBM-held a discussion forum involving surgeons, endocrinologists, cardiologists, nutritionists, psychiatrists, and physical exercise professionals. After critical analysis of the available literature in the light of the prior experience of participants, objective classification criteria were drawn up. The following is a list of the final decisions reached by the panel of experts: 1. A patient who does not manage adequately to control obesity is different from one who experiences a relapse after various years of adequate control. 2. A small long-term weight gain is normal and to be expected after bariatric and metabolic surgery. 3. The control of metabolic diseases and the consequent improvement in quality of life are the desired outcomes. 4. It is appropriate for the criteria for successful or unsuccessful surgery to employ the following terms: Controlled obesity: patients who achieve a Total Weight Loss of > 20% in 6 months; Partially controlled obesity: Total Weight Loss of between 10 and 20% in 6 months; Uncontrolled obesity: Total Weight Loss of < 10% in 6 months. 5. Along with the definition of Obesity Control, the following factors should also be taken into consideration: Patient satisfaction with the outcome; Improvement of associated diseases, irrespective of weight loss; Any weight also occurring prior to surgery. 6. For those patients who gain weight after a long period of control or those in whom an associated disease has reappeared the correct term is obesity recidivism, classified as follows: Recidivism: 50% of weight lost regained in long term or 20% of weight regained in association with reappearance of comorbidities. Controlled Recidivism: Between 20 and 50% of weight loss regained in long term. NB. Expected weight gain: < 20% of weight loss regained in long term. 7. The causes of post-operative recidivism are related to factors relating to the patient (behavioral and biological) and surgical techniques. 8. The causes related to recidivism, especially behavioral ones, should first be evaluated by a multidisciplinary team and then the technical causes should be solved surgically. 9. We consider the ideal multidisciplinary team to comprise: an endocrinologist a surgeon a nutritional doctor a psychiatrist a nutritionist a psychologist a physical trainer a physiotherapist and other professionals if necessary. Always leading the way, the SBCBM has established guidelines to help orient the outcomes of bariatric and metabolic surgery. Standardized terms and criteria will lead to standardized practices and provide better treatment for our patients. It is important to note that this document should not be used for legal purposes, as it does not deal with legislation on the subject, aiming only to provide instrutions for members of the society.
  7 in total

Review 1.  Weight recidivism post-bariatric surgery: a systematic review.

Authors:  Shahzeer Karmali; Balpreet Brar; Xinzhe Shi; Arya M Sharma; Christopher de Gara; Daniel W Birch
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Bariatric surgery and long-term cardiovascular events.

Authors:  Lars Sjöström; Markku Peltonen; Peter Jacobson; C David Sjöström; Kristjan Karason; Hans Wedel; Sofie Ahlin; Åsa Anveden; Calle Bengtsson; Gerd Bergmark; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Kristina Narbro; Ingmar Näslund; Torsten Olbers; Per-Arne Svensson; Lena M S Carlsson
Journal:  JAMA       Date:  2012-01-04       Impact factor: 56.272

Review 3.  Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.

Authors:  L Sjöström
Journal:  J Intern Med       Date:  2013-02-08       Impact factor: 8.989

4.  Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass.

Authors:  Silas M Chikunguwo; Luke G Wolfe; Patricia Dodson; Jill G Meador; Nancy Baugh; John N Clore; John M Kellum; James W Maher
Journal:  Surg Obes Relat Dis       Date:  2009-11-10       Impact factor: 4.734

5.  Effect of improved glycemic control on health care costs and utilization.

Authors:  E H Wagner; N Sandhu; K M Newton; D K McCulloch; S D Ramsey; L C Grothaus
Journal:  JAMA       Date:  2001-01-10       Impact factor: 56.272

6.  Lifetime costs of complications resulting from type 2 diabetes in the U.S.

Authors:  J Jaime Caro; Alexandra J Ward; Judith A O'Brien
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

7.  Comparative effectiveness of bariatric surgery vs. nonsurgical treatment of type 2 diabetes among severely obese adults.

Authors:  David Arterburn; Andy Bogart; Karen J Coleman; Sebastien Haneuse; Joe V Selby; Nancy E Sherwood; Stephen Sidney; Mary Kay Theis; Guilherme M Campos; David McCulloch; Patrick J O' Connor
Journal:  Obes Res Clin Pract       Date:  2013 Jul-Aug       Impact factor: 2.288

  7 in total
  5 in total

1.  Weight Regain 10 Years After Roux-en-Y Gastric Bypass.

Authors:  Daniela Vicinansa Monaco-Ferreira; Vânia Aparecida Leandro-Merhi
Journal:  Obes Surg       Date:  2017-05       Impact factor: 4.129

2.  Impact of Weight Regain on the Evolution of Non-alcoholic Fatty Liver Disease After Roux-en-Y Gastric Bypass: a 3-Year Follow-up.

Authors:  Laísa Simakawa Jimenez; Fábio Henrique Mendonça Chaim; Felipe David Mendonça Chaim; Murillo Pimentel Utrini; Martinho Antonio Gestic; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

3.  Effects of Resistance Training With or Without Protein Supplementation on Body Composition and Resting Energy Expenditure in Patients 2-7 Years PostRoux-en-Y Gastric Bypass: a Controlled Clinical Trial.

Authors:  Fernando Lamarca; Flávio Teixeira Vieira; Ricardo Moreno Lima; Eduardo Yoshio Nakano; Teresa Helena Macedo da Costa; Nathalia Pizato; Eliane Said Dutra; Kênia Mara Baiocchi de Carvalho
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

4.  Status of bariatric endoscopy-what does the surgeon need to know? A review.

Authors:  Diogo Turiani Hourneaux de Moura; Anna Carolina Batista Dantas; Igor Braga Ribeiro; Thomas R McCarty; Flávio Roberto Takeda; Marco Aurelio Santo; Sergio Carlos Nahas; Eduardo Guimarães Hourneaux de Moura
Journal:  World J Gastrointest Surg       Date:  2022-02-27

5.  FABP2, LEPR223, LEP656, and FTO Polymorphisms: Effect on Weight Loss 2 Years After Bariatric Surgery.

Authors:  Natália Luiza Kops; Manoela A Vivan; Jaqueline D C Horvath; Mariana L D de Castro; Rogério Friedman
Journal:  Obes Surg       Date:  2018-09       Impact factor: 4.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.